Vanda pharmaceuticals inc. (VNDA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net Income (Loss) Attributable to Parent

486

4,216

100,423

11,526

-612

10,360

7,171

4,611

3,066

-1,838

-4,550

-1,534

-7,645

-604

-430

-4,618

-12,358

-14,798

-9,460

-5,386

-10,221

69,719

-1,425

-21,575

-26,533

-7,747

-5,406

-3,383

-4,519

-6,369

-5,326

-8,007

-7,962

-5,523

-3,074

-1,341

136

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation of property and equipment

351

378

350

340

332

343

351

357

349

305

342

303

250

246

219

216

219

162

157

123

140

134

132

139

125

111

109

105

107

105

104

93

331

185

146

61

77

Stock-based compensation

3,944

3,668

3,407

3,101

3,282

2,922

2,872

2,721

3,151

2,782

2,771

2,656

2,256

2,103

2,100

2,074

2,266

1,887

2,061

2,068

1,945

1,631

1,411

1,443

1,393

1,407

1,565

1,134

1,298

923

576

1,193

1,402

1,318

1,254

1,325

1,604

Amortization of discounts and premiums on marketable securities

287

472

779

942

906

835

714

464

208

152

127

94

53

14

-33

-15

-28

-65

-186

-229

-197

-42

-36

-43

-53

-34

0

-1

-120

-144

-134

-165

-117

-126

-200

-259

-315

Intangible asset amortization

400

405

300

420

380

380

397

350

400

432

432

432

454

2,105

2,943

2,942

2,943

2,943

2,943

2,942

4,144

536

536

617

565

377

377

372

369

377

377

372

369

377

377

372

369

Deferred income taxes

879

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash adjustments, net

-314

-268

-777

-423

-317

-14

-40

-226

113

-188

-189

-77

-133

-59

-257

-214

-12

176

-345

-75

-239

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Landlord contributions for tenant improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

3,553

-1,728

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

2,905

-428

2,937

-2,417

-2,434

3,521

392

1,581

5,713

-436

-2,845

3,272

-2,516

4,350

2,018

-2,418

348

542

-29

-4,302

16,466

-42

1,320

685

-340

75

315

179

294

-367

-165

165

-83

402

464

-143

384

Prepaid expenses and other assets

3,524

-192

3,637

-434

-247

322

193

2,480

1,263

-2,629

-4,944

3,475

446

760

819

3,096

1,484

-4,334

3,020

4,453

-581

-764

-381

1,034

429

291

-239

-637

-679

483

-104

940

-435

1,126

-235

573

-224

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-705

292

-

-798

54

826

-803

-599

909

-216

-337

-4

503

186

Inventory

-76

-174

705

147

44

145

-286

134

-63

164

889

-76

83

-137

-326

305

-42

66

-245

-253

45

942

175

901

192

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and other liabilities

-1,795

317

-1,968

1,652

3,507

2,564

-1,614

1,163

-2,731

1,401

1,906

1,204

1,442

-1,155

-651

-4,574

6,955

1,695

-1,009

-2,107

10,853

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue allowances

1,184

-1,123

-154

1,332

706

3,474

490

-426

4,685

-2,587

-5,695

1,367

-4,181

1,015

-719

1,452

-3,174

4,140

2,672

14,055

14,188

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-51

-2

208

208

208

210

-361

314

129

-11

-8

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,934

-

762

-104

-1,313

-1,566

845

537

1,990

-250

897

372

817

Accrued income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,108

-113

-51

6

Deferred licensing revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,591

-7,765

-7,764

-7,452

-6,752

-6,753

-6,678

-6,606

-6,752

-6,753

-6,678

-6,606

-6,752

-6,753

-6,678

-6,606

Net cash provided by operating activities

-907

9,791

5,998

20,515

9,643

15,263

8,694

4,391

1,638

3,466

2,168

-2,260

-5,357

-1,183

1,241

-3,262

-4,899

-356

-4,851

12,101

5,555

-13,386

-7,599

-36,665

-23,904

-12,153

-10,271

-8,043

-9,125

-13,849

-10,164

-12,214

-8,690

-12,357

-7,170

-5,619

-3,264

Cash flows from investing activities
Acquisition of intangible asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,000

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

373

68

294

264

393

22

136

75

135

191

371

624

478

-

-

-

-

714

874

156

783

338

53

243

135

97

7

49

23

7

17

148

1,845

-

-

-

-

Purchases of marketable securities

41,400

103,184

100,040

90,490

100,803

80,455

71,404

100,103

30,433

38,739

28,225

27,704

53,467

34,547

26,865

56,682

47,311

65,502

46,261

21,458

59,890

52,960

19,839

18,225

2,319

-

-

-

-

10,899

0

20,773

29,194

19,576

51,061

42,176

47,400

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

750

1,000

7,198

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

62,073

97,022

86,460

79,000

64,745

64,673

62,635

23,915

46,880

46,291

34,000

22,500

36,777

43,378

29,832

43,494

40,083

70,630

46,856

23,450

27,105

24,790

24,857

27,735

3,500

-1

0

1,000

30,500

9,000

19,809

17,431

59,900

50,920

68,700

45,925

60,625

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-100

-145

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

20,300

-6,230

-13,874

-11,754

-36,451

-15,804

-8,905

-101,263

16,312

7,361

5,404

-5,828

-17,168

8,134

2,368

-13,299

-7,228

4,414

-279

2,835

-33,568

-28,508

5,715

10,367

389

-65,696

-7

951

30,477

-1,906

20,291

-1,492

28,861

39,934

17,105

3,485

13,225

Cash flows from financing activities
Proceeds from Issuance of Common Stock

-

-

-

-

-

0

0

-198

101,068

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Stock Options Exercised

500

2,200

500

3,400

200

800

100

2,734

2,666

130

768

2,193

2,209

750

5,962

1,015

24

0

3,579

592

203

174

198

32

2,447

488

265

795

2

-

-

-

-

-

-

-

-

Tax obligations paid in connection with settlement of restricted stock units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

282

0

0

0

436

0

0

1

195

-

-

-

-

-

-

-

-

Net cash provided by financing activities

479

2,116

558

3,411

179

792

112

2,488

103,734

81

768

2,193

2,209

750

5,962

1,015

24

-1

3,579

592

-79

87,487

198

32

2,011

441

48,817

794

-193

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents and restricted cash

5

23

-19

-7

2

-24

-14

-18

18

8

14

19

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash

19,877

5,700

-7,337

12,165

-26,627

227

-113

-94,402

121,702

10,916

8,354

-5,876

-20,315

7,706

9,571

-15,546

-12,103

4,057

-1,551

15,528

-28,092

45,593

-1,686

-26,266

-21,504

-77,408

38,539

-6,298

21,159

-15,743

10,127

-13,706

20,171

27,597

9,940

-2,134

9,961